PCB vs CARE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 06, 2026

PCB

40.7
AI Score
VS
CARE Wins

CARE

57.8
AI Score

Investment Advisor Scores

PCB

41score
Recommendation
HOLD

CARE

58score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PCB CARE Winner
Revenue 2.90M 20.32M CARE
Net Income 37.45M 31.36M PCB
Net Margin 1291.9% 154.4% PCB
ROE 9.6% 7.5% PCB
ROA 1.1% 0.6% PCB
Total Assets 3.28B 4.85B CARE
Cash 207.14M 105.16M PCB
Free Cash Flow 24.40M 31.81M CARE

Relative Price Performance (Last 90 Days)

PCB 1M: +7.4% · 3M: +5.1% CARE 1M: -3.2% · 3M: -10.6%

Current Technical Phase

PCB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.0% over 20 days), RSI 60

RSI (14): 60.0 · Price: $29.96

CARE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.9%), weak momentum, RSI 44

RSI (14): 43.9 · Price: $29.22

Fundamentals Snapshot

Metric PCB CARE
Market Cap — —
Forward P/E 9.3 11.7
Trailing P/E 10.3 5.0
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 1.0% 1.0%
Operating Margin 0.5% 0.2%
EPS 2.96 5.91
Dividend Yield 0.03% 0.01%

Frequently Asked Questions

Based on our detailed analysis, CARE is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.